SEARCH

SEARCH BY CITATION

References

  • 1
    Ohnaka K, Takayanagi R, Nishikawa M, Haji M, Nawata H ( 1993) Purification and characterization of a phosphoramidon-sensitive endothelin-converting enzyme in porcine aortic endothelium. J Biol Chem 268: 2675926766.
  • 2
    Kuruppu S, Smith AI ( 2012) Endothelin converting enzyme-1 phosphorylation and trafficking. FEBS Lett 586: 22122217.
  • 3
    Schweizer A, Valdenaire O, Nelbock P, Deuschle U, Dumas Milne Edwards JB, Stumpf JG, Loffler BM ( 1997) Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations. Biochem J 328: 871877.
  • 4
    Valdenaire O, Lepailleur-Enouf D, Egidy G, Thouard A, Barret A, Vranckx R, Tougard C, Michel JB ( 1999) A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter molecular cloning and characterization. Eur J Biochem/FEBS 264: 341349.
  • 5
    Jafri F, Ergul A ( 2006) Phosphorylation of endothelin converting enzyme-1 isoforms: relevance to subcellular localization. Exp Biol Med 231: 713717.
  • 6
    Smith AI, Lew RA, Thomas WG, Tochon-Danguy N ( 2006) Protein kinase C regulates the cell surface activity of endothelin-converting enzyme-1. Int J Pept Res Ther 12: 291295.
  • 7
    MacLeod KJ, Husain RD, Gage DA, Ahn K ( 2002) Constitutive phosphorylation of human endothelin-converting enzyme-1 isoforms. J Biol Chem 277: 4635546363.
  • 8
    Kuruppu S, Tochon-Danguy N, Smith AI ( 2012) Protein kinase C recognition sites in the cytoplasmic domain of endotheliln converting enzyme-1c. Biochem Biophys Res Commun 427: 606610.
  • 9
    Keynan S, Khamaisi M, Dahan R, Barnes K, Jackson CD, Turner AJ, Raz I ( 2004) Increased expression of endothelin-converting enzyme-1c isoform in response to high glucose levels in endothelial cells. J Vasc Res 41: 131140.
  • 10
    Kuruppu S, Tochon-Danguy N, Ian Smith A ( 2010) Role of protein kinase C in endothelin converting enzyme-1 trafficking and shedding from endothelial cells. Biochem Biophys Res Commun 398: 173177.
  • 11
    Jeng AY ( 2003) Utility of endothelin-converting enzyme inhibitors for the treatment of cardiovascular diseases. Curr Opin Investig Drugs 4: 10761081.
  • 12
    Martinez-Miguel P, Raoch V, Zaragoza C, Valdivielso JM, Rodriguez-Puyol M, Rodriguez-Puyol D, Lopez-Ongil S ( 2009) Endothelin-converting enzyme-1 increases in atherosclerotic mice: potential role of oxidized low density lipoproteins. J Lipid Res 50: 364375.
  • 13
    Pluta RM, Boock RJ, Afshar JK, Clouse K, Bacic M, Ehrenreich H, Oldfield EH ( 1997) Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 87: 287293.
  • 14
    Smollich M, Wulfing P ( 2008) Targeting the endothelin system: novel therapeutic options in gynecological, urological and breast cancers. Exp Rev Anticancer Ther 8: 14811493.
  • 15
    Kuruppu S, Reeve S, Ian Smith A ( 2007) Characterisation of endothelin converting enzyme-1 shedding from endothelial cells. FEBS Lett 581: 45014506.
  • 16
    Morawietz H, Duerrschmidt N, Niemann B, Galle J, Sawamura T, Holtz J ( 2001) Induction of the oxLDL receptor LOX-1 by endothelin-1 in human endothelial cells. Biochem Biophys Res Commun 284: 961965.
  • 17
    Rosano L, Spinella F, Di Castro V, Decandia S, Nicotra MR, Natali PG, Bagnato A ( 2006) Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression. Exp Biol Med 231: 11281131.
  • 18
    Smollich M, Gotte M, Yip GW, Yong ES, Kersting C, Fischgrabe J, Radke I, Kiesel L, Wulfing P ( 2007) On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer. Breast Can Res Treat 106: 361369.
  • 19
    Tavare JM, Fletcher LM, Welsh GI ( 2001) Using green fluorescent protein to study intracellular signalling. J Endocrin 170: 297306.
  • 20
    Hanakam F, Albrecht R, Eckerskorn C, Matzner M, Gerisch G ( 1996) Myristoylated and non-myristoylated forms of the pH sensor protein hisactophilin II: intracellular shuttling to plasma membrane and nucleus monitored in real time by a fusion with green fluorescent protein. EMBO J 15: 29352943.
  • 21
    Rizzuto R, Brini M, De Giorgi F, Rossi R, Heim R, Tsien RY, Pozzan T ( 1996) Double labelling of subcellular structures with organelle-targeted GFP mutants in vivo. Curr Biol 6: 183188.
  • 22
    Viallet PM, Vo-Dinh T ( 2003) Monitoring intracellular proteins using fluorescence techniques: from protein synthesis and localization to activity. Curr Prot Peptide Sci 4: 375388.